TCL Archive Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent January 8, 1982
TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
TCL Archive Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals September 9, 1977
TCL Archive In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril May 30, 1975